A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1–insensitive models of triple-negative breast cancer-Reference-Cited by-同舟云学术

A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1–insensitive models of triple-negative breast cancer

Published:2018-11-15 Issue:22 Volume:3 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Cheng Ning,Watkins-Schulz Rebekah,Junkins Robert D.,David Clément N.,Johnson Brandon M.,Montgomery Stephanie A.,Peine Kevin J.,Darr David B.,Yuan Hong,McKinnon Karen P.,Liu Qi,Miao Lei,Huang Leaf,Bachelder Eric M.,Ainslie Kristy M.,Ting Jenny P-Y

Funder

National Institutes of Health

North Carolina Biotechnology Center

Lineberger Comprehensive Cancer Center, University of North Carolina

National Cancer Institute

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/120638/files/pdf

Reference64 articles.

1. Pembrolizumab versus Ipilimumab in Advanced Melanoma

2. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

3. The future of cancer treatment: immunomodulation, CARs and combination immunotherapy;Khalil;Nat Rev Clin Oncol,2016

4. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

5. Inhibition of PD-L1 by MPDL3280A leads to clinical activity in patients with metastatic triple-negative breast cancer;Emens;Cancer Res,2015

Cited by 200 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-associated macrophages within the immunological milieu: An emerging focal point for therapeutic intervention;Heliyon;2024-09

2. Targeting tumor-associated macrophages with nanocarrier-based treatment for breast cancer: A step toward developing innovative anti-cancer therapeutics;Heliyon;2024-09

3. A metabolic switch orchestrated by IL-18 and the cyclic dinucleotide cGAMP programs intestinal tolerance;Immunity;2024-09

4. Recent Review on Biological Barriers and Host–Material Interfaces in Precision Drug Delivery: Advancement in Biomaterial Engineering for Better Treatment Therapies;Pharmaceutics;2024-08-16

5. Biosynthetic MnSe nanobomb with low Mn content activates the cGAS-STING pathway and induces immunogenic cell death to enhance antitumour immunity;Acta Biomaterialia;2024-08